Table III.
Significantly enriched KEGG signaling pathways of the differentially expressed genes identified in multiple myeloma.
| KEGG ID | KEGG term | No. of enriched genes | FDR | Genes |
|---|---|---|---|---|
| hsa03010 | Ribosome | 13 | 2.25×10−16 | RPS15A, RPS27A, RPS25, RPS13, RPL26,RPL39, RPL21, RPS29, RPS14, RPS27, RPL11, RPL27, RPS10 |
| hsa00190 | Oxidative phosphorylation | 4 | 2.77×10−02 | NDUFS4, ATP6V1A, ATP5I, ATP6V0C |
| hsa05100 | Bacterial invasion of epithelial cells | 3 | 2.86×10−02 | CLTC, RHOA, CRKL |
| hsa04142 | Lysosome | 4 | 3.18×10−02 | CLTC, PSAP, ATP6V0C, LAMP2 |
| hsa04310 | Wnt signaling pathway | 4 | 3.43×10−02 | SIAH1, RAC2, RHOA, FRAT1 |
| hsa05152 | Tuberculosis | 4 | 3.85×10−02 | APAF1, RHOA, ATP6V0C, LAMP2 |
| hsa04966 | Collecting duct acid secretion | 2 | 4.07×10−02 | ATP6V1A, ATP6V0C |
KEGG, Kyoto Encyclopedia of Genes and Genomes; FDR, false discovery rate.